Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights
Hepatocellular carcinoma (HCC) continues to be a significant global health concern, ranking third in mortality rates among all cancer types. Despite therapeutic advancements, doxorubicin (DOX) remains a cornerstone chemotherapeutic agent in the treatment of HCC. However, its efficacy is often limite...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
AUC Knowledge Fountain
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613431477043200 |
|---|---|
| access_status_str | Open Access |
| author | Abdelaal, Noha Mohamed |
| author_browse | Abdelaal, Noha Mohamed |
| author_facet | Abdelaal, Noha Mohamed |
| author_sort | Abdelaal, Noha Mohamed |
| collection | Thesis |
| description | Hepatocellular carcinoma (HCC) continues to be a significant global health concern, ranking third in mortality rates among all cancer types. Despite therapeutic advancements, doxorubicin (DOX) remains a cornerstone chemotherapeutic agent in the treatment of HCC. However, its efficacy is often limited by the development of drug resistance. Increased cellular capacity to repair DNA damage is a key molecular mechanism underlying DOX resistance. MicroRNAs (miRNAs) are a family of small, non-protein-coding RNA molecules that regulate gene expression post-transcriptionally. They have emerged as critical regulators of tumorigenesis and are considered promising biomarkers and therapeutic targets. Among them, miR-203a-3p has been implicated in modulating chemoresistance in various cancer types, though its role in HCC remains unclear. In this study, we employed a comprehensive approach to investigate the functional role of miR-203a-3p in response to DOX treatment in HCC. To elucidate the underlying mechanisms, we combined cytotoxicity assays, gene expression analysis, apoptosis assays, and metabolic profiling, using HepG2 and Huh7 cells, which differ in p53 status. Our findings offer new insights into the role of miR-203a-3p in the context of HCC chemoresistance, with potential implications for therapeutic interventions. Understanding the molecular and metabolic underpinnings of miR-203a3p function may inform the development of more effective miRNA-based combination therapies to overcome chemoresistance and improve treatment outcomes. |
| format | Thesis |
| id | oai:fount.aucegypt.edu:etds-3673 |
| institution | American University in Cairo (Egypt) |
| last_indexed | 2026-06-10T12:35:59.828Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from AUC Knowledge Fountain — bepress |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | AUC Knowledge Fountain |
| publisherStr | AUC Knowledge Fountain |
| record_format | dspace |
| source_str | AUC Knowledge Fountain — bepress |
| spelling | oai:fount.aucegypt.edu:etds-3673 MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights Abdelaal, Noha Mohamed Hepatocellular carcinoma (HCC) continues to be a significant global health concern, ranking third in mortality rates among all cancer types. Despite therapeutic advancements, doxorubicin (DOX) remains a cornerstone chemotherapeutic agent in the treatment of HCC. However, its efficacy is often limited by the development of drug resistance. Increased cellular capacity to repair DNA damage is a key molecular mechanism underlying DOX resistance. MicroRNAs (miRNAs) are a family of small, non-protein-coding RNA molecules that regulate gene expression post-transcriptionally. They have emerged as critical regulators of tumorigenesis and are considered promising biomarkers and therapeutic targets. Among them, miR-203a-3p has been implicated in modulating chemoresistance in various cancer types, though its role in HCC remains unclear. In this study, we employed a comprehensive approach to investigate the functional role of miR-203a-3p in response to DOX treatment in HCC. To elucidate the underlying mechanisms, we combined cytotoxicity assays, gene expression analysis, apoptosis assays, and metabolic profiling, using HepG2 and Huh7 cells, which differ in p53 status. Our findings offer new insights into the role of miR-203a-3p in the context of HCC chemoresistance, with potential implications for therapeutic interventions. Understanding the molecular and metabolic underpinnings of miR-203a3p function may inform the development of more effective miRNA-based combination therapies to overcome chemoresistance and improve treatment outcomes. 2026-01-31T08:00:00Z thesis application/pdf https://fount.aucegypt.edu/etds/2617 https://fount.aucegypt.edu/context/etds/article/3673/viewcontent/Noha_Mohamed_Abdelaal_Thesis.pdf Theses and Dissertations AUC Knowledge Fountain Hepatocellular Carcinoma; Doxorubicin Resistance; miR-203a-3p; p53 Signaling; TAp63 Signaling; Apoptosis; Metabolic Rewiring Life Sciences Medicine and Health Sciences |
| spellingShingle | Hepatocellular Carcinoma; Doxorubicin Resistance; miR-203a-3p; p53 Signaling; TAp63 Signaling; Apoptosis; Metabolic Rewiring Life Sciences Medicine and Health Sciences Abdelaal, Noha Mohamed MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights |
| title | MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights |
| title_full | MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights |
| title_fullStr | MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights |
| title_full_unstemmed | MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights |
| title_short | MicroRNA-203a-3p as a Modulator of Doxorubicin Resistance in Hepatocellular Carcinoma: Molecular and Metabolic Insights |
| title_sort | microrna 203a 3p as a modulator of doxorubicin resistance in hepatocellular carcinoma molecular and metabolic insights |
| topic | Hepatocellular Carcinoma; Doxorubicin Resistance; miR-203a-3p; p53 Signaling; TAp63 Signaling; Apoptosis; Metabolic Rewiring Life Sciences Medicine and Health Sciences |
| url | https://fount.aucegypt.edu/etds/2617 https://fount.aucegypt.edu/context/etds/article/3673/viewcontent/Noha_Mohamed_Abdelaal_Thesis.pdf |
| work_keys_str_mv | AT abdelaalnohamohamed microrna203a3pasamodulatorofdoxorubicinresistanceinhepatocellularcarcinomamolecularandmetabolicinsights |